| Baseline (t0) | 12 weeks post-randomization (t1) | 6 months post-randomization (t2) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | IG (n = 13) | CG (n = 15) | IG (n =11) | CG (n =13) | IG (n =11) | CG (n =12) | ||||||
Outcome | M | SD | M | SD | M | SD | M | SD | M | SD | M | SD |
PHQ-ADS | 14.77 | 8.96 | 11.40 | 6.31 | 11.18 | 7.81 | 9.38 | 4.66 | 10.91 | 9.74 | 13.83 | 7.20 |
VAS* | 70.31 | 17.20 | 73.00 | 18.90 | 75.09 | 20.00 | 69.54 | 17.96 | 69.20 | 24.75 | 63.75 | 25.37 |
CODI* | 77.92 | 8.30 | 80.80 | 8.76 | 76.00 | 6.03 | 81.08 | 8.62 | 77.80 | 7.60 | 80.83 | 9.34 |
GSE* | 24.69 | 5.30 | 29.07 | 5.50 | 28.73 | 4.86 | 30.15 | 4.49 | 27.80 | 4.76 | 29.33 | 4.62 |
CATS | 17.08 | 9.12 | 12.87 | 7.52 | 13.18 | 9.80 | 14.85 | 7.99 | 11.50 | 11.99 | 15.75 | 7.64 |
SRGS* | 16.54 | 7.24 | 14.00 | 6.62 | 16.73 | 7.18 | 15.08 | 7.18 | 17.80 | 9.54 | 12.17 | 5.52 |
AUDIT | 1.92 | 2.50 | 2.27 | 2.15 | 1.82 | 2.23 | 1.46 | 1.56 | 1.50 | 1.90 | 1.75 | 1.82 |
BSSS* | 43.38 | 4.57 | 41.60 | 4.45 | 43.00 | 6.45 | 42.08 | 4.03 | 42.70 | 5.93 | 43.91 | 6.82 |
IUES | 27.31 | 9.11 | 26.33 | 7.00 | 24.45 | 7.30 | 24.08 | 8.83 | 24.50 | 9.79 | 26.00 | 8.06 |
Usage-I | 20.84 | 20.87 | 15.38 | 8.58 | 16.45 | 13.06 | 15.54 | 18.19 | 6.36 | 28.97 | 14.67 | 12.07 |
Usage-S | 12.85 | 25.93 | 17.92 | 15.30 | 18.82 | 10.64 | 17.96 | 24.85 | 5.18 | 24.35 | 15.92 | 13.64 |
BADS* | 77.23 | 18.60 | 90.13 | 14.01 | 83.91 | 18.02 | 92.69 | 16.47 | 88.00 | 16.64 | 86.00 | 18.81 |
ATQ-R | 33.69 | 17.38 | 28.33 | 13.80 | 28.36 | 15.34 | 23.30 | 12.79 | 31.20 | 20.48 | 29.75 | 15.26 |